Paper Details

  1. Home
  2. Paper Details

Prevention of community-acquired pneumonia.

Author: La ForceF M, OrtizC R

Journal ArticleAn article published in an academic or professional journal that reports original research or scholarly analysis.
ReviewAn article that critically examines existing research on a particular topic and summarizes the current state of knowledge in the field.

Overview

Influenza and pneumococcal vaccines, antiviral agents like rimantadine, and antibiotics in selected cases are effective preventive measures against community-acquired pneumonia.
Paper Details　
Original Abstract of the Article :
Preventive measures against CAP are important yet underused. Cost-effective preventive measures against CAP include influenza and pneumococcal vaccines, especially in patients over the age of 65 and other high-risk groups. There are now two antiviral agents, amantadine and rimantadine, that can be u...See full text at original site
Dr.Camel IconDr.Camel's Paper Summary Blogラクダ博士について

ラクダ博士は、Health Journal が論文の内容を分かりやすく解説するために作成した架空のキャラクターです。
難解な医学論文を、専門知識のない方にも理解しやすいように、噛み砕いて説明することを目指しています。

* ラクダ博士による解説は、あくまで論文の要点をまとめたものであり、原論文の完全な代替となるものではありません。詳細な内容については、必ず原論文をご参照ください。
* ラクダ博士は架空のキャラクターであり、実際の医学研究者や医療従事者とは一切関係がありません。
* 解説の内容は Health Journal が独自に解釈・作成したものであり、原論文の著者または出版社の見解を反映するものではありません。


引用元：
https://doi.org/10.1016/s0025-7125(16)30125-0

データ提供：米国国立医学図書館（NLM）

Preventing Community-Acquired Pneumonia: A Multifaceted Strategy

Community-acquired pneumonia (CAP) is a significant health concern, especially for vulnerable populations. This review explores various preventive measures against CAP, highlighting the importance of vaccination, antiviral medications, and other strategies. The authors emphasize the role of influenza and pneumococcal vaccines in reducing the incidence of CAP, particularly in high-risk groups. The review also discusses the potential benefits of antiviral medications and other interventions, providing valuable insights for preventing this common respiratory infection.

Building Defenses Against Pneumonia: The Power of Vaccines

The review strongly advocates for the use of influenza and pneumococcal vaccines, especially for individuals over 65 years old and other high-risk groups. It highlights the efficacy of these vaccines in reducing the incidence of CAP, providing a crucial preventative measure.

Beyond Vaccines: Exploring Other Preventative Measures

The review goes beyond vaccination, exploring other preventive strategies for CAP. It emphasizes the potential benefits of antiviral medications, particularly rimantadine, for both prophylaxis and treatment of influenza A virus infections. The review also discusses the role of antibiotics and gamma globulin infusions in specific patient populations, offering a comprehensive overview of available interventions.

Dr.Camel's Conclusion

This review provides a valuable guide to preventing community-acquired pneumonia. It emphasizes the importance of vaccination, antiviral medications, and other interventions, offering a multifaceted approach to combatting this common respiratory infection.

Date :
  1. Date Completed 1994-10-04
  2. Date Revised 2019-08-17
Further Info :

Pubmed ID

8078374

DOI: Digital Object Identifier

10.1016/s0025-7125(16)30125-0

Related Literature

Article Analysis
・Side Effects of rimantadine
SNS
PICO Info
in preparation
Languages

English

Positive IndicatorAn AI analysis index that serves as a benchmark for how positive the results of the study are. Note that it is a benchmark and requires careful interpretation and consideration of different perspectives.

This site uses cookies. Visit our privacy policy page or click the link in any footer for more information and to change your preferences.